PerkinElmer’s life science and diagnostics spinoff rebranded as Revvity earlier this week. The company, which serves customers across the pharmaceutical, biotech, diagnostic labs sectors, said in a ...

Revvity, Inc. is set to boldly unveil its new branding while showcasing more than 40 products from its life sciences and diagnostics portfolio at SLAS2024 to be held in Boston from February 3-7 in ...

Revvity is set to announce its fourth-quarter results soon, and analysts expect a single-digit rise in its adjusted earnings ...

WALTHAM, Mass.--(BUSINESS WIRE)--Revvity, Inc. is set to boldly unveil its new branding while showcasing more than 40 products from its life sciences and diagnostics portfolio at SLAS2024 to be held ...

Bill McColl has 25+ years of experience as a senior producer and writer for TV, radio, and digital media leading teams of anchors, reporters, and editors in creating news broadcasts, covering some of ...

Revvity, Inc. RVTY announced that its subsidiary EUROIMMUN has introduced the UNIQO 160 (CE-IVDR), a new automated system for indirect immunofluorescence test (IIFT), for autoimmune disease ...

Revvity, Inc., announced today the launch of the in-vitro diagnostic EURORealTime ™ APOE assay in European countries that accept the CE mark, which will enable accurate genotyping of the APOE gene.

Revvity Inc. (NYSE:RVTY) stock is trading lower on Monday following the life science tools maker’s second-quarter 2025 earnings report, which also included a trimmed profit forecast for 2025. The ...

Oct 30 (Reuters) - Revvity Inc RVTY.N cut its full-year sales and revenue forecasts after missing Wall Street estimates for third-quarter results, hurt by weak demand for its supplies to life science ...

Revvity has acquired companies in sectors with high-growth potential, such as cell and gene therapies, and precision medicine, among other sectors. The company has strengthened its debt position, ...